Peringkat dalam Saham
#38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Harga Saham
$0.08765138
Terakhir disinkronkan: 2025-12-23
Kapitalisasi Pasar
$1.11M
Perubahan (1 tahun)
-28.78%
Perdagangan Psyence Group Inc. (PSYG)
Harga PSYG dengan kapitalisasi pasar B
Kapitalisasi pasar dari Psyence Group Inc.(PSYG)
Kapitalisasi Pasar: $1.11M
Per August 2026, Psyence Group Inc. memiliki kapitalisasi pasar sebesar $1.11M. Ini menjadikan Psyence Group Inc. sebagai perusahaan 38237th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Psyence Group Inc. dari 2021 hingga 2026
PSYG dibandingkan dengan 5 teratas stocks paling populer
| Harga PSYG |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+489,312,468.90%
|
|
|
|
|
$4.490T
|
+402,985,337.44%
|
|
|
|
|
$4.162T
|
+373,581,610.11%
|
|
|
|
|
$3.676T
|
+329,956,650.81%
|
|
|
|
|
$2.833T
|
+254,269,341.74%
|
